骨髓增生异常综合征RAS基因突变的分子学特征及预后意义

OBJECTIVE: To explore the molecular features and prognostic value of RAS mutations in patients with myelodysplastic syndromes（MDS）. METHODS: 112-gene targeted sequencing was conducted to detect RAS mutations in 776 patients with newly diagnosed primary MDS from December 2011 to December 2018. The mu...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595862/
https://www.ncbi.nlm.nih.gov/pubmed/33113603
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595862/
https://www.ncbi.nlm.nih.gov/pubmed/33113603
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.004

Ejemplares similares